Medac Gesellschaft für klinische Spezialpräparate mbH (manufacturer responsible for labeling, secondary packaging and batch release)

The drug is used in combination therapy for the treatment of acute lymphoblastic leukemia in children (from birth to 18 years) and adults.

Dosage form: powder for concentrate for infusion solution

ATC: L01XX02